Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus

• Главные авторы: Noël Zahr (Автор), Saik Urien (Автор), Christian Funck-Brentano (Автор), Hélène Vantomme (Автор), Nicolas Garcelon (Автор), Isabelle Melki (Автор), Margaux Boistault (Автор), Olivia Boyer (Автор), Brigitte Bader-Meunier (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2021-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Hydroxychloroquine (HCQ) is an antimalarial agent given to patients with systemic lupus erythematosus (SLE) as first-line therapy. It alleviates childhood-onset systemic lupus erythematosus cSLE skin and musculoskeletal disease, decreasing disease activity and flares. HCQ concentration-e...